loading
Schlusskurs vom Vortag:
$39.60
Offen:
$39.78
24-Stunden-Volumen:
2.47M
Relative Volume:
0.98
Marktkapitalisierung:
$4.67B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$251.00M
KGV:
20.01
EPS:
1.9744
Netto-Cashflow:
$-193.86M
1W Leistung:
+4.89%
1M Leistung:
+23.67%
6M Leistung:
+26.04%
1J Leistung:
+259.74%
1-Tages-Spanne:
Value
$39.01
$40.05
1-Wochen-Bereich:
Value
$38.19
$41.00
52-Wochen-Spanne:
Value
$10.63
$41.00

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Name
Firmenname
Indivior Pharmaceuticals Inc
Name
Telefon
804-379-1090
Name
Adresse
10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD
Name
Mitarbeiter
838
Name
Twitter
Name
Nächster Verdiensttermin
2026-04-30
Name
Neueste SEC-Einreichungen
Name
INDV's Discussions on Twitter

Compare INDV vs TAK, TEVA, HLN, ZTS, UTHR

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
INDV icon
INDV
Indivior Pharmaceuticals Inc
39.50 4.67B 1.29B 251.00M -193.86M 1.9744
TAK icon
TAK
Takeda Pharmaceutical Co Adr
16.46 52.00B 29.85B 776.90M 4.35B 0.2408
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
35.73 41.60B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.11 40.43B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
82.83 34.72B 9.47B 2.67B 2.28B 6.0218
UTHR icon
UTHR
United Therapeutics Corp
564.94 23.98B 3.18B 1.33B 1.04B 27.90

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-06 Eingeleitet H.C. Wainwright Buy
2025-07-22 Fortgesetzt Jefferies Buy
2025-01-28 Eingeleitet Rodman & Renshaw Buy
2024-07-23 Eingeleitet Piper Sandler Overweight
2024-04-03 Eingeleitet Craig Hallum Buy
2023-07-13 Eingeleitet Northland Capital Outperform
Alle ansehen

Indivior Pharmaceuticals Inc Aktie (INDV) Neueste Nachrichten

pulisher
12:44 PM

Indivior launches $175M accelerated share buyback - MSN

12:44 PM
pulisher
May 09, 2026

Indivior Pharmaceuticals Inc. (INDV) Q1 earnings and revenues beat estimates - MSN

May 09, 2026
pulisher
May 08, 2026

Indivior Pharmaceuticals Inc. (INDV) is a great momentum stock: Should you buy? - MSN

May 08, 2026
pulisher
May 08, 2026

Indivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should know - MSN

May 08, 2026
pulisher
May 08, 2026

Zacks.com featured highlights include The Vita Coco Company, Indivior Pharmaceuticals and Marathon Petroleum - Yahoo Finance

May 08, 2026
pulisher
May 07, 2026

Wall Street analysts predict a 27.76% upside in Indivior Pharmaceuticals Inc. (INDV): Here's what you should know - MSN

May 07, 2026
pulisher
May 06, 2026

New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations - Quantisnow

May 06, 2026
pulisher
May 05, 2026

Why Indivior Pharmaceuticals (INDV) Is Up 9.8% After Raising 2026 Revenue Guidance And Earnings - Sahm

May 05, 2026
pulisher
May 05, 2026

Indivior Pharmaceuticals Inc. (INDV) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Indivior Pharmaceuticals Inc. (INDV) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Here's why momentum in Indivior Pharmaceuticals Inc. (INDV) should keep going - MSN

May 05, 2026
pulisher
May 05, 2026

Wall Street Analysts Predict a 27.76% Upside in Indivior Pharmaceuticals Inc. (INDV): Here's What You Should Know - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Best Momentum Stock to Buy for May 5th - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News - Sahm

May 05, 2026
pulisher
May 04, 2026

Indivior Announces $175 Million Accelerated Share Repurchase Agreement Under Existing Authorization - Minichart

May 04, 2026
pulisher
May 04, 2026

Indivior Announces $175 Million Accelerated Share Repurchase - TipRanks

May 04, 2026
pulisher
May 04, 2026

Indivior starts $175M buyback with 3.7M shares due upfront - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Indivior enters $175M accelerated share repurchase, receives 3.72M initial shares - TradingView

May 04, 2026
pulisher
May 04, 2026

Indivior (INDV) 10K Form and Latest SEC Filings 2026 - MarketBeat

May 04, 2026
pulisher
May 02, 2026

Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum - The Globe and Mail

May 02, 2026
pulisher
May 02, 2026

Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After A 214% One-Year Surge? - Yahoo Finance

May 02, 2026
pulisher
May 02, 2026

Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After Its 214% One-Year Surge? - Sahm

May 02, 2026
pulisher
May 01, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Bausch + Lomb Corporation (BLCO) and Indivior (INDV) - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

Indivior Pharmaceuticals Q1 2026 Deep Dive: EPS Beats by 43.3%, Revenue Up 19% - AlphaStreet

May 01, 2026
pulisher
May 01, 2026

Indivior (INDV) Q1 2026 Earnings Transcript - AOL.com

May 01, 2026
pulisher
May 01, 2026

Here's Why Momentum in Indivior Pharmaceuticals Inc. (INDV) Should Keep going - Yahoo Finance

May 01, 2026
pulisher
May 01, 2026

Indivior PLC Q1 2026 Earnings Call Summary - Yahoo Finance

May 01, 2026
pulisher
May 01, 2026

Indivior Posts Strong Q1 Results, Raises 2026 Outlook - The Globe and Mail

May 01, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:INDV) 2026-04-30 - Seeking Alpha

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals Crushes Q1 2026 Profit Estimates by 43.3% - AlphaStreet

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Q1 2026 Earnings Call Transcript - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior (INDV) Raises FY26 Guidance on Strong SUBLOCADE Performance - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior (INDV) Reports Strong Q1 Revenue Growth - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Is Indivior (INDV) 56.5% Overvalued After Q1 2026? Revenue $317M - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Q1 Earnings Call Highlights - Yahoo Finance

Apr 30, 2026
pulisher
Apr 30, 2026

Earnings call transcript: Indivior Q1 2026 sees strong results, stock surges - Investing.com Canada

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals Inc (NASDAQ:INDV) Smashes Q1 Estimates and Lifts Full-Year Outlook as SUBLOCADE Sales Surge - ChartMill

Apr 30, 2026
pulisher
Apr 30, 2026

Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Reports Q1 Revenue $317.0M, vs. FactSet Est of $272.8M - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.96 per Share, vs. FactSet Est of $0.66 - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimates - TradingView

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior (NASDAQ: INDV) lifts 2026 guidance on SUBLOCADE growth and margin expansion - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance - Moomoo

Apr 30, 2026

Finanzdaten der Indivior Pharmaceuticals Inc-Aktie (INDV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
RDY RDY
$13.23
price down icon 1.49%
$23.65
price down icon 1.50%
RGC RGC
$29.28
price down icon 6.96%
$152.25
price up icon 1.78%
$17.17
price down icon 1.27%
$564.94
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):